The University of Queensland

The Queensland-Pfizer Program for Diabetes and Cardiovascular Drug Discovery (2012–2014)

Abstract:

Type 2 diabetes, obesity and cardiovascular diseases threaten the lives and quality of life of many Queenslanders, impacting on Queensland health and economic prosperity.

Grant type:

Queensland Government Smart Futures Co-Investment Fund

Researchers:

• 

  Professor David Fairlie

  NHMRC Leadership Fellow and Group L
  

  Institute for Molecular Bioscience

• 

  Professor David Craik

  UQ Laureate Fellow - GL
  

  Institute for Molecular Bioscience

Funded by:

Queensland Department of Employment, Economic Development and Innovation